Digital health M&A picks up, driven by AI and private equity
Flare Capital Expert Roundtable Series #20: AI in Pharma Innovation: From Molecule to Market
Visana Health secures $24 Million in Series A funding
Investing in Peer AI
At Flare Capital Partners, we are thrilled to announce our lead investment in the latest financing round for Peer AI, a pioneering agentic AI platform transforming life sciences regulatory documentation. Today, Peer AI announced $12.1 million in total funding, led by Flare Capital Partners and SignalFire. We are also excited to be joined by our […]
The chatbot therapist problem
Introducing the Flare Capital AI Advisory Council: Transforming the Future of Healthcare AI
Today we are excited to introduce our latest initiative: the Flare Capital AI Advisory Council. This dynamic new Council convenes senior executives from our strategic partners and leading technology experts to accelerate innovation at the intersection of healthcare and AI. We are thrilled to tackle this work with our incredible founding Council members, which include […]
Another Great Add to the Flare Capital Team
We could not be more excited to announce that Alyssa Tsenter has joined the firm as a Senior Associate. Venture capital firms add to their investment teams infrequently, so each hire is important and deliberate with an extended interview process to assess capabilities, commitment, and all-around compatibility. While we will make a few hundred investment decisions together […]
Billions in Play: Healthcare AI’s Race for Market Dominance
Investing in Cascala Health
We are thrilled to share that Flare Capital Partners has deepened our partnership with Cascala Health, an AI-enabled care transitions software platform transforming how patients move between care settings. Today, Cascala announced the close of its $8.6 million Seed financing, co-led by Flare Capital Partners and Eniac Ventures, and welcomed additional new investors Omega Healthcare […]
Investing in Isaac Health
Neurological disease remains a leading cause of illness and disability worldwide. In the United States alone, the annual economic burden of Alzheimer’s disease and related dementias is now estimated at $780 billion and rising as the baby-boomer generation ages. Yet, more than nine in ten cases of mild cognitive impairment go undiagnosed and over 20 […]